AstraBio (China) Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $7.42M

  • Investors
  • 13

AstraBio (China) General Information

Description

Manufacturer of in vitro diagnostics intended for patient healthcare optimization. The company utilizes enzyme-linked immunosorbent assay, polymerase chain reaction and microarray platforms to detect human hormones, genetic disorders, tumor markers and allergens, providing laboratories and biomedical partners with reagents and diagnostic kits to enable personalized medicine and individual patient therapy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 14, Liandong U Valley
  • Number 200 Xingpu Road, Shengpu Town
  • Suzhou, Jiangsu 215123
  • China
+86 0512
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Corporate Office
  • Building 14, Liandong U Valley
  • Number 200 Xingpu Road, Shengpu Town
  • Suzhou, Jiangsu 215123
  • China
+86 0512

AstraBio (China) Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AstraBio (China) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series B) 31-Aug-2026 $7.42M Completed Generating Revenue
8. Secondary Transaction - Private 13-Jul-2026 Completed Generating Revenue
7. Later Stage VC 27-May-2024 Completed Generating Revenue
6. Early Stage VC 13-Mar-2024 Completed Generating Revenue
5. Secondary Transaction - Private 12-Jul-2023 Completed Generating Revenue
4. Early Stage VC 26-Mar-2023 Completed Generating Revenue
3. Early Stage VC (Series A) 29-Jun-2022 Completed Generating Revenue
2. Early Stage VC 28-Jul-2021 Completed Generating Revenue
1. Early Stage VC 27-Sep-2020 Completed Generating Revenue
To view AstraBio (China)’s complete valuation and funding history, request access »

AstraBio (China) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AstraBio (China) Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Taizhou Jintai Private Equity Fund Management Government Minority
Univ-Bio Corporation Minority
LH Ventures (China) PE/Buyout Minority
Annoroad VC-Backed Company Minority
Zhengxuan Investment Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

AstraBio (China) Acquisitions (1)

AstraBio (China)’s most recent deal was a Merger/Acquisition with Renrui. The deal was made on 09-Oct-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Renrui 09-Oct-2021 Merger/Acquisition Diagnostic Equipment
To view AstraBio (China)’s complete acquisitions history, request access »

AstraBio (China) Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Renrui Xiamen, China 2012

AstraBio (China) FAQs

  • When was AstraBio (China) founded?

    AstraBio (China) was founded in 2019.

  • Where is AstraBio (China) headquartered?

    AstraBio (China) is headquartered in Suzhou, China.

  • What is the size of AstraBio (China)?

    AstraBio (China) has 8 total employees.

  • What industry is AstraBio (China) in?

    AstraBio (China)’s primary industry is Diagnostic Equipment.

  • Is AstraBio (China) a private or public company?

    AstraBio (China) is a Private company.

  • What is AstraBio (China)’s current revenue?

    The current revenue for AstraBio (China) is .

  • How much funding has AstraBio (China) raised over time?

    AstraBio (China) has raised $22.3M.

  • Who are AstraBio (China)’s investors?

    Taizhou Jintai Private Equity Fund Management, Univ-Bio, LH Ventures (China), Annoroad, and Zhengxuan Investment are 5 of 13 investors who have invested in AstraBio (China).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process